prikaz prve stranice dokumenta Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
  Preuzmi
PDF 2.07 MB
Znanstveni rad - Pregledni rad
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
European Journal of Medical Research, 28 (2023), 1; 345. https://doi.org/10.1186/s40001-023-01275-4
Mohi-ud-din, Roohi; Chawla, Apporva; Sharma, Pooja; Mir, Prince Ahad; Potoo, Faheem Hyder; Reiner, Željko; Reiner, Ivan; Ateşşahin, Dilek Arslan; Sharifi-Rad, Javad; Mir, Reyaz Hassan; Calina, Daniela

Citiranost:
,
Citirajte ovaj rad

Mohi ud din, R., Chawla, A., Sharma, P., Mir, P. A., Potoo, F. H., Reiner, Ž. ... Calina, D. (2023). Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects. European Journal of Medical Research, 28. (1). doi: 10.1186/s40001-023-01275-4

Mohi ud din, Roohi, et al. "Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects." European Journal of Medical Research, vol. 28, br. 1, 2023. https://doi.org/10.1186/s40001-023-01275-4

Mohi ud din, Roohi, Apporva Chawla, Pooja Sharma, Prince Ahad Mir, Faheem Hyder Potoo, Željko Reiner, Ivan Reiner, et al. "Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects." European Journal of Medical Research 28, br. 1 (2023). https://doi.org/10.1186/s40001-023-01275-4

Mohi ud din, R., et al. (2023) 'Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects', European Journal of Medical Research, 28(1). doi: 10.1186/s40001-023-01275-4

Mohi ud din R, Chawla A, Sharma P, Mir PA, Potoo FH, Reiner Ž, i sur.. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects. European Journal of Medical Research [Internet]. 14.09.2023. [pristupljeno 07.04.2025.];28(1). doi: 10.1186/s40001-023-01275-4

R. Mohi ud din, et al., "Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects", European Journal of Medical Research, vol. 28, br. 1, Rujan 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:442193. [Citirano: 07.04.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:442193
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
AutorRoohi Mohi-ud-din
AutorApporva Chawla
AutorPooja Sharma
AutorPrince Ahad Mir
AutorFaheem Hyder Potoo
AutorŽeljko Reiner
AutorIvan Reiner
AutorDilek Arslan Ateşşahin
AutorJavad Sharifi-Rad
AutorReyaz Hassan Mir
AutorDaniela Calina
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Cancer poses a significant global health challenge, with predictions of increasing prevalence in the coming years due to limited prevention, late diagnosis, and inadequate success with current therapies. In addition, the high cost of new anti-cancer drugs creates barriers in meeting the medical needs of cancer patients, especially in developing countries. The lengthy and costly process of developing novel drugs further hinders drug discovery and clinical implementation. Therefore, there has... Više been a growing interest in repurposing approved drugs for other diseases to address the urgent need for effective cancer treatments. The aim of this comprehensive review is to provide an overview of the potential of approved non-oncology drugs as therapeutic options for cancer treatment. These drugs come from various chemotherapeutic classes, including antimalarials, antibiotics, antivirals, anti-inflammatory drugs, and antifungals, and have demonstrated significant antiproliferative, pro-apoptotic, immunomodulatory, and antimetastatic properties. A systematic review of the literature was conducted to identify relevant studies on the repurposing of approved non-oncology drugs for cancer therapy. Various electronic databases, such as PubMed, Scopus, and Google Scholar, were searched using appropriate keywords. Studies focusing on the therapeutic potential, mechanisms of action, efficacy, and clinical prospects of repurposed drugs in cancer treatment were included in the analysis. The review highlights the promising outcomes of repurposing approved non-oncology drugs for cancer therapy. Drugs belonging to different therapeutic classes have demonstrated notable antitumor effects, including inhibiting cell proliferation, promoting apoptosis, modulating the immune response, and suppressing metastasis. These findings suggest the potential of these repurposed drugs as effective therapeutic approaches in cancer treatment. Repurposing approved non-oncology drugs provides a promising strategy for addressing the urgent need for effective and accessible cancer treatments. The diverse classes of repurposed drugs, with their demonstrated antiproliferative, pro-apoptotic, immunomodulatory, and antimetastatic properties, offer new avenues for cancer therapy. Further research and clinical trials are warranted to explore the full potential of these repurposed drugs and optimize their use in treating various cancer types. Repurposing approved drugs can significantly expedite the process of identifying effective treatments and improve patient outcomes in a cost-effective manner. Sakrij dio sažetka
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaEuropean Journal of Medical Research
Brojčani podacivol. 28, br. 1, 345
e-ISSN2047-783X
DOIhttps://doi.org/10.1186/s40001-023-01275-4
URN:NBNurn:nbn:hr:105:442193
Datum objave publikacije2023-09-14
URL dokumentahttps://eurjmedres.biomedcentral.com/articles/10.1186/s40001-023-01275-4
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-05-22 11:09:40
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.